Protease inhibitors for treatment of chronic hepatitis C--a new target for the magic bullet identified

Affiliations

¹ Department of Internal Medicine IV, Division of Gastroenterology and Hepatology, Vienna General Hospital (AKH), University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. peter.ferenci@akh-wien.ac.at

Comment

Peter Ferenci. J Hepatol. 2004 Jan.

. 2004 Jan;40(1):184-6.

doi: 10.1016/j.jhep.2003.10.015.

¹ Department of Internal Medicine IV, Division of Gastroenterology and Hepatology, Vienna General Hospital (AKH), University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. peter.ferenci@akh-wien.ac.at

No abstract available

Comment on

Triggering the interferon antiviral response through an IKK-related pathway.
Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Sharma S, et al. Science. 2003 May 16;300(5622):1148-51. doi: 10.1126/science.1081315. Epub 2003 Apr 17. Science. 2003. PMID: 12702806
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.
Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr. Foy E, et al. Science. 2003 May 16;300(5622):1145-8. doi: 10.1126/science.1082604. Epub 2003 Apr 17. Science. 2003. PMID: 12702807